BNGO - Bionano Genomics announces inducement grants

Bionano Genomics (NASDAQ:BNGO) has announced inducement grants under Nasdaq Listing Rule 5635(c)(4). Bionano's Chief Informatics Officer Soheil Shams has been granted an option to purchase up to 400,000 shares of the company's common stock. Additionally, 18 employees, in connection with Bionano's acquisition of BioDiscovery, have been granted options to purchase up to an aggregate of 454,000 shares of common stock. The shares subject to each option will vest over four years, with 25% of the shares subject to each option vesting on the one-year anniversary of the vesting commencement date of October 18, 2021 and the balance of the shares vesting in a series of 36 successive equal monthly installments thereafter. Each of the foregoing stock options has an exercise price of $5.40/share, which is equal to the closing price of Bionano's common stock on November 1, 2021, the grant date. BNGO -1.48% AH

For further details see:

Bionano Genomics announces inducement grants